University Hospitals Case Medical Center and Case Western Reserve University Announce Licensing Agreement for the Development of Diagnostic Tests for HIV Drug ResistanceJuly 2, 2013 6:00 am | by The Associated Press | News | Comments
Case Western Reserve University has signed an exclusive worldwide licensing agreement granting University Hospitals (UH) Case Medical Center rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus (HIV). The phenotypic and...
An early-stage company aims to commercialize new optical materials for denser data storage and better cancer treatments.A startup focused on developing novel optical materials received $1 million in first-round funding last month from the venture capital firm Quantum Wave Fund to advance its early-stage technology.
As Parker sees it, the three biggest obstacles to [design] success for patient care products, such as oxygen concentrators and ventilators, are portability, battery life, and reliability. To make home care products more portable, Parker has reduced the size of some valves up to 75%.
As more therapies are able to indicate implantable devices for treatment, incorporating drug delivery into them can be a significant additional benefit. Even when drug delivery is the primary function, implantable devices can be preferable. This article reviews some representative applications that device designers can leverage in developing new products for the implantable drug delivery market.
Value Plastics, a Nordson Company, has introduced a new line of barbed check valves as an extension to their SCV Series of check valves. Most medical grade check valves incorporate solvent bonded end fitments that require costly material handling and increase the risk of contamination and cracking due to chemical incompatibility introduced through solvents.
A complete solution for automatically assembling chips, sensors and small electronic components to boards and devices with the highest level of precision and accuracy. Automated vision system optimized for miniature components adds pattern recognition and theta correction along with inspection.
ZOLL Medical Corporation has purchased the assets of CoAxia, an early revenue stage medical device company that provides catheter-based perfusion augmentation therapies to improve outcomes for patients with cerebral ischemia resulting from vasospasm, following subarachnoid hemorrhage.
Biomaterials are increasingly replacing human organs and tissues and silver is added to reduce the adhesion of bacteria to biomaterials and prevent infections. However, a recent study by researchers in Portugal suggests that – in one material – increasing levels of silver may indirectly promote bacterial adhesion.
An estimated two-thirds of all Americans are overweight or obese and many find it difficult to lose weight and keep it off. They've tried fad diets, exercise programs, diet pills and other methods but the battle continues. Now, a new study suggests that watching an avatar model weight-loss behavior in a virtual community might help some women shed pounds in the real world.
DNA fragments in your blood may someday help doctors quickly learn if chest pain means you have narrowed heart arteries, according to a new study published in the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology.
Thoratec has acquired the DuraHeart II ventricular assist system from Terumo Corporation for an upfront cash payment of $13 million and potential future milestone payments, based on regulatory approvals and product sales, of up to $43.5 million.
Covidien, a leading global provider of healthcare products, today announced it has completed the separation of its Pharmaceuticals business, which is now held by Mallinckrodt plc, a new independent company. Mallinckrodt will begin “regular way” trading on the New York Stock Exchange today under the symbol "MNK."
Fox Electronics is now offering its XpressO TCXO with tighter stabilities in custom frequencies up to 250 MHz. Available with ±1.5 ppm from -40°C to +85°C as well as down to ±1 ppm from 0°C to +70°C, the new XpressO-TC HCMOS TCXO oscillators can be delivered in ten working days or less.
Altuglas International has introduced Altuglas Luctor polymethyl methacrylate (PMMA) alloy that flows twice far as conventional transparent medical polymers in thin wall injection mold cavities.
Veracyte, Inc., a molecular diagnostics company in the field of molecular cytology, today announced the completion of the final tranche of its $28 million Series C financing. The financing included GE Ventures as a new investor, as well as existing investors Domain Associates, Kleiner Perkins Caufield & Byers, TPG Biotech, and Versant Ventures.